Authored by our Global Head of Generics, Dr. Ayaaz Hussain Khan, this article explores the meteoric rise of the biosimilar market, expected to reach $240 billion by 2030 and takes a deep dive into the 5 key trends that we are witnessing for 2021.

Please complete the form to download a copy of the article. 

Published in Pharma Focus Asia Magazine Issue 44 | September, 2021 | Pages 12 - 16

© 2021 Navitas Life Sciences | Privacy Policy